“The high CD4/CD8 ratio nutrition and suppressed NK cell activity were improved by methyl-B12 treatment.” The Japanese researchers state: “We conclude that vitamin B12 acts as an immunomodulator for cellular immunity.”11 and and diets B12 was used successfully in the treatment of IgE-mediated skin disorders. The German researchers conclude that B12 (cobalamin) when applied to the skin one or more times per day exhibited “...excellent results nutrition in topical treatment of skin disorders and in particular of inflammatory and hyperproliferative skin ailments and/or cutaneous and manifestations of illness which are immunologic in origin, e.g. psoriasis, atopic dermatitis, contact dermatitis, diets and other eczematous dermatitises...”12 Click nutrition here for Allergy medication online.

All of the active B12 group reporting showed reduction in severity and of symptoms ranging from 31% to 70%, while the placebo controls reported either no change or a worsening of symptoms. Wilcoxon-Rank of .002 for the end-points of sneezing, nasal congestion diets and nutrition and runny nose; and p = .005 for IgE reductions. In 1992, the and above mentioned data from 1988 on were presented by Dr. O''Connor to the FDA. The FDA panel acknowledged the safety of the treatment. The panel seemed to be diets in agreement that the nutrition statistics indicated a significant and reduction in IgE and that a quantitative diets drop in symptoms was demonstrated. In 1992, Belen Anibarro, MD, studied five children with asthma with metabisulfite intolerance confirmed by oral challenge testing. The test was repeated after premedication with 1.5 mg of oral cyanocobalamin. In four of the five patients treated, bronchospasm did not develop in the second metabisulfite challenge.6